Uterine cancer prevention vaccine age

The vaccine is recommended for women aged 9 to 45 years. Vaccination at

this age provides better protection against uterine cancer. The immune system is more active at this time, and it is more likely to produce effective antibody responses, thus providing stronger protection against uterine cancer. For young people aged 15 to 26 years, who are often sexually active and at higher risk of HPV infection, vaccination can effectively reduce the risk of infection with relevant HPV types and reduce the risk of uterine cancer. For people aged 26 to 45, the immune response may be relatively weak, but it can still prevent HPV infection and uterine cancer to some extent.